On Air Now

Listen

Listen Live Now » 101.9 FM Central Wisconsin

Weather

Current Conditions(Wausau,WI 54403)

More Weather »
75° Feels Like: 75°
Wind: SSW 10 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Clear 54°

Tomorrow

Mostly Sunny 78°

Wed Night

Scattered Thunderstorms 66°

Alerts

Novartis withdraws marketing application for Ruvise

LONDON (Reuters) - Swiss drugmaker Novartis has withdrawn a marketing application for its drug Ruvise, designed to treat arterial hypertension, the European Medicines Agency (EMA) said on Thursday.

The drug, known generically imatinib mesilate, was intended for use in adults as add-on therapy for the treatment of pulmonary arterial hypertension (PAH), the drug regulator said in a statement.

EMA reported that Novartis had said that the withdrawal was because it requires additional data to address the regulator's questions relating to its benefit-risk assessment.

The data would not be available within the timeframe allowed in the centralized procedure, it said.

(Reporting by Kate Kelland; Editing by David Goodman)

Comments